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Ultrasonography and contrast sonohysterography are used to select patients at risk for benign and malignant intracavitary lesions. Contrast sonography was originally performed by instilling saline solution and was called saline contrast sonohysterography or saline infusion sonography.\[[@ref1]\] Recently, the gel has been proposed as an alternative to saline: gel instillation sonography.\[[@ref2][@ref3][@ref4][@ref5]\]

In 2009, a prospective observational cohort study, comparing saline infusion sonography and gel instillation sonography, showed no difference in technical feasibility nor diagnostic accuracy, while the reported procedure-related pain was less in the gel instillation sonography group.\[[@ref3]\]

In comparison with saline, gel also has some additional physical advantages owing to its higher viscosity: less backflow through the cervix, a more stable filling of the uterine cavity and consequently, a smaller required instillation volume.\[[@ref3]\]

Malignant lesions may be missed using blind sampling, by office sampling or dilatation and curettage.\[[@ref6]\]

It is, therefore, recommended to combine sampling with imaging (hysteroscopy or contrast ultrasound) to prevent false-negative results. Hysteroscopy, saline infusion sonography, and gel instillation sonography are equally accurate in the triage of patients at risk for endometrial cancer in whom the histological examination is needed.\[[@ref3][@ref4][@ref7][@ref8]\] However, the costs of an intraoperative hysteroscopy in comparison with saline infusion sonography and gel instillation sonography are higher.\[[@ref9][@ref10]\]

It has already been proven that, in case of endometrial cancer, seeding of malignant cells from the uterine cavity into the abdominal cavity occurs during hysteroscopy as well as during saline infusion sonography.\[[@ref11][@ref12][@ref13][@ref14]\] Despite the association between hysteroscopy/saline infusion sonography and positive peritoneal cytology, it has not yet been demonstrated that this seeding of cancer cells results in peritoneal metastasis, disease recurrence, or poorer prognosis.\[[@ref15]\] However, out of precaution, hysteroscopy guidelines advocate to use the least intrauterine pressure and the smallest volume necessary to achieve the diagnosis.\[[@ref16][@ref17]\]

It is believed that the higher the instillation rates and the lower the fluid viscosity, the more transtubal flow is to be expected. Therefore, transtubal spillage is thought to be less likely with gel instillation sonography than with saline instillation sonography.\[[@ref4]\] However, currently, no prospective studies have been done to confirm this hypothesis.

The aim of this prospective study is to examine whether there is less transtubal flow with gel instillation sonography than with saline infusion sonography.

S[UBJECTS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
================================================

This study was designed as a monocentric randomized controlled *in vitro* trial on hysterectomy specimens conducted at the Department of Obstetrics and Gynaecology of the University Hospitals Leuven, Belgium.

We intended to include 20 patients because this is an explorative study and we assumed a significant difference after the inclusion of 20 persons.

Patients were eligible for inclusion if they were of at least 18 years of age, mentally competent and if they were scheduled for a hysterectomy with bilateral salpingectomy or with bilateral salpingo-oophorectomy. The exclusion criteria were a history of sterilization or previous bilateral salpingectomy, visible damage on the integrity of the uterine cavity and/or tubes, and malignancy.

The study was approved by the Ethics Committee of the University Hospitals Leuven (S60115). Experimental procedures followed the ethical standards for experimentation on humans declared by the 1975 Declaration of Helsinki. Written informed consent was obtained in all patients.

For the randomization, a random integer generator (<https://www.random.org>) was used to generate 20 random integers (one: first saline or two: first gel). A third person, who did not participate in the study, put the numbers (one or two) in numbered and sealed envelopes (numbered from 1 to 20).

In each group, patients were compared to detect a difference in patency, volume, intracavitary fluid in the sagittal plane (mm), and instillation pressure when using gel or saline.

Subsequently, the two groups were compared to evaluate if there was a difference by first using gel or saline.

Descriptive statistics were performed with R Studio (R Foundation for Statistical Computing, Vienna, Austria) and GraphPad Prism v5.01 (GraphPad Software, La Jolla California, USA), applying the Wilcoxon Signed Rank test for quantitative and McNemar test for binary outcomes.

All procedures were carried out with the same equipment and by the same investigators. In the operation room, the hysterectomy specimen was immediately placed in a container with warmed (at 36°C) Plasmalyte^®^ and kept in an isothermal box. The temperature of these isotonic solutions was between 30°C and 37°C using the heating oven (Memmert^®^). The examination was performed at the ultrasound department within 1 h after the surgical procedure.

Before starting the procedure, 0.1 ml green ink (Waterman^®^ Harmonious Green Ink) was equally mixed with 20 cc of saline (BD PosiFlushTM SP NaCl 0,9%) (Becton Dickinson, Eynsins, Switzerland) and 0.1 ml blue ink (Waterman^®^ Serenity Blue Ink) was mixed with 20 cc of Endosgel^®^ (FARCO-PHARMA GmbH, Cologne, Germany). For the measurement of the ink volume, a U-100 insulin syringe was used. The saline and the gel were warmed to a temperature between 30°C and 37°C.

To maintain uterine submersion, the uterus was fixed with an elastic band attached to little jars filled with small pebbles \[[Figure 1](#F1){ref-type="fig"}\]. Hereafter, the uterus was placed in Plasmalyte^®^ during the whole procedure to respect the physiology as much as possible.\[[@ref18][@ref19]\]

![Study setup](JMU-28-35-g001){#F1}

First, an underwater ultrasound examination was performed to check the presence of pre-existing fluid in the uterine cavity. In case there was some liquid inside, this was removed by aspiration with a Pipelle^®^ catheter (CooperSurgical, Inc., Venlo, Netherlands).

Second, a uVue^®^ (Cook Medical) balloon catheter was inserted into the uterine cavity. The balloon was filled with 1-cc saline. The fluid instillation was performed by the first author (ST).

Depending on the randomization, saline (group one) or gel (group two) was used first to fill the uterine cavity. For the fluid instillation a 5-cc syringe was used. The instillation was continued until bilateral tubal patency was noticed or till a maximal volume of ten cc was used.

As soon as tubal patency was noticed, the instillation volume was recorded.

A subjective score between 1 and 10, indicating the pressure necessary to fill the uterus, was also recorded.

Next, the maximal diameter of the fluid in the uterine cavity was measured in the sagittal plane. This measurement was recorded as soon as tubal patency was noticed or at the end of the instillation in the absence of patency.

If applicable, the possible anatomical reason for the absence of tubal patency was described.

Subsequently, the balloon catheter was removed to let the fluid leak out of the uterine cavity. If needed the remaining fluid was aspirated by a Pipelle^®^ catheter. Underwater ultrasonography was performed to confirm that the uterine cavity was empty.

Third, these steps were repeated with gel (group two) or with saline (group one), according to the randomization. If needed the isotonic solution in the bucket was changed to keep the solution clear.

Two-dimensional images and three-dimensional volumes were pre-, per- and post-procedurally rendered by the second author (RH) (GE Voluson E10 Expert, GE Medical Systems, Zipf, Austria).

After completing these steps, the tissue was sent to the laboratory for routine anatomopathological research. Before the start of this study, it had been ascertained that the ink used did not interfere with the anatomopathological examination. Because after the inclusion of 15 patients one of the principal investigators (ST) was no longer available to perform the tests, we decided to stop further inclusions to maintain correct results and avoid confounders.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Of the 15 patients, seven were randomized to group one (saline first) and eight to group two (gel first).

The reason for hysterectomy was presence of myoma(s) (*n* = 9), BRCA 1 mutation (*n* = 2), cervical intraepithelial neoplasia 3 (*n* = 1), hereditary nonpolyposis colorectal cancer (*n* = 1), ovarian mass (*n* = 1), and adenomyosis (*n* = 1).

In total, unilateral or bilateral tubal patency was noticed in eight cases with saline (53.3%) and in two cases with gel (11.1%). McNemar\'s Chi-squared test for the comparison of the resulting patency among the two instillation types, showed apparent favor of gel instillation (*P* = 0.008), with an odds ratio (OR) of 4.88 (95% confidence interval between 0.88 and 39.28) \[[Figure 2](#F2){ref-type="fig"}\].

![Binary outcome graph comparing tubal patency between saline and gel](JMU-28-35-g002){#F2}

Concerning randomization versus patency, in group one, patency was seen five times with saline (71.4%) and once with gel (14.2%). In group two, patency was noticed three times with saline (37.5%) and once with gel (12.5%) \[[Figure 3](#F3){ref-type="fig"}\].

![Binary dot graph comparing the occurrence of tubal patency between the fluid types accounting for their respective timing of instillation](JMU-28-35-g003){#F3}

The mean cavitary expansion after an instillation volume of 5 cc was equal for saline and gel (10 mm). After instillation of 10 cc, only a little difference in mean expansion was noticed, resulting in noninferiority and possibly even a trend in favor of gel \[[Figure 4](#F4){ref-type="fig"}\].

![Graph comparing observed cavitary expansion at predefined instilled volumes](JMU-28-35-g004){#F4}

The median volume necessary to show patency was 5 cc with saline versus 6 cc with gel.

The lowest instillation volume necessary to notice patency was 2 cc in the saline group, whereas in the gel group, patency could only be evidenced if at least 5 cc was injected \[Figures [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}\].

![Graph summarizing the observed volumes resulting in tubal patency](JMU-28-35-g005){#F5}

![Kaplan--Meier curve comparing probability of nonpatency among the two fluid types with respect to the infused volumes](JMU-28-35-g006){#F6}

Regarding the subjective instillation pressure during saline infusion sonography and gel instillation sonography, higher pressure is needed during gel instillation sonography \[[Figure 7](#F7){ref-type="fig"}\] (*P* \< 0.001 applying Wilcoxon\'s Signed Rank test).

![Graph depicting instillation pressure assigned by a dedicated examiner on a scale from 0 to 10](JMU-28-35-g007){#F7}

The possible reason for the absence of tubal patency was checked and described in [Table 1](#T1){ref-type="table"}.

###### 

Randomization during instillation procedure and reasons for hysterectomy and possible reasons of absent tubal patency

  Reason for hysterectomy   Randomization   Reason for the absence of tubal patency
  ------------------------- --------------- -----------------------------------------
  Myoma (menorrhagia)       1               N/A
  Myoma                     2               N/A
  HNPCC                     1               no anatomical reason
  BRCA1                     2               N/A
  Myoma (menorrhagia)       1               Myomatous uterine obstruction
  Myoma (menorrhagia)       2               N/A
  Ovarian mass              2               Cervical insufficiency
  Myoma (menorrhagia)       2               Myomatous/gel-based uterine obstruction
  CIN3                      1               N/A
  BRCA1                     1               N/A
  Myoma (menorrhagia)       1               N/A
  Myoma (menorrhagia)       2               Myomatous/gel-based uterine obstruction
  Adenomyosis               1               N/A
  Myoma (menorrhagia)       2               Myomatous/gel-based uterine obstruction
  Myoma (menorrhagia)       2               Myomatous/gel-based uterine obstruction

HNPCC: Hereditary nonpolyposis colorectal cancer, CIN: Cervical intraepithelial neoplasia, N/A: Not available

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

This study is the first randomized controlled *in vitro* trial comparing tubal patency during saline versus gel instillation, demonstrating lesser patency and hence, a possible reduced risk for transtubal cell seeding during gel instillation.

Our data show that transtubal flow is less likely with gel instillation sonography than with saline infusion sonography. Consequently, the hypothesis that lower fluid viscosity could cause more transtubal flow seems to be correct.

The trend toward reduced patency in those randomized to "gel first" may be caused by a transient blocking effect of gel within the tubes.

The lowest instillation volume necessary to notice patency was 2 cc in the saline group, whereas in the gel group, patency could only be evidence if at least 5 cc was injected.

In clinical practice, the instillation of gel up to 3 cc is generally enough to rule out focal intracavitary disease. In contrast, a higher volume of saline is often necessary to obtain a sufficient distention of the uterine cavity. In literature, the average instillation volume of saline varies between 5 and 20 cc.\[[@ref20][@ref21]\]

Owing to its viscosity, instillation pressures were perceived as significantly higher when using the gel as directly as compared to that of saline. This allows for lower infusion velocities, better control over cavitary pressure build-up and superior maintenance of minimally required dilation. A lower instillation velocity precludes rapid unintentional intracavitary volume expansion and hence reduces the risk for higher transtubal flow volumes.

Although there is no evidence so far demonstrating a correlation between positive peritoneal cytology, caused by diagnostic hysteroscopy or saline infusion sonography, and the prognosis of patients with endometrial cancer, transtubal cell seeding remains a matter of concern. Therefore, out of precaution, hysteroscopy guidelines advocate to use the lowest possible intrauterine pressure and the smallest volume necessary to achieve the diagnosis.

To minimize risks, we suggest using gel instead of saline infusion or diagnostic hysteroscopy as the first test in the diagnosis of intracavitary uterine lesions, including cancer. Our data show that using a maximum instillation volume of 4 cc gel, the risk of transtubal flow is minimal.

The principal strength of this study is randomization. Furthermore, the instillations and sonographic examinations were always performed by the same persons to avoid interobserver variability.

The principal limitation concerns the small series, which is expressed in the large confidence interval of OR when looking to tubal patency versus medium (saline/gel). Therefore, our findings should be confirmed in larger series.

Another restriction is that different uterine pathology may interfere with patency. In the past, many hysterectomies were performed for dysfunctional bleeding or intrauterine lesions such as endometrial polyps. Nowadays, with the advanced hormonal therapy options and operative hysteroscopy, a hysterectomy is rarely the treatment of choice if the uterine cavity is intact, but rather in cases of intramural fibroids or adenomyosis. Therefore, we did not exclude uterine leiomyomas.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

The current data suggest that gel instillation has a safer profile as to the risk of transtubal flow and hence a possible reduced risk for transtubal cell seeding. Gel instillation sonography may, therefore, prove to be the diagnostic test of choice in women with abnormal uterine bleeding. However, as this is an *in vitro* trial and *in vivo* studies in larger series are necessary to confirm these results.
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